Keith Katkin

MC10, Inc. develops stretchable silicon materials for the microelectronics industry. The firm's technology uses semiconductors in conjunction with interconnect and packaging technologies to produce conformal electronics. It offers solutions for applications in consumer electronics, medical devices, industrial products, defense systems, differentiated consumer products, industrial, and military markets. The company was founded by Carmichael S. Roberts Jr., John A. Rogers, Benjamin Schlatka, Marvin J. Slepian, George M. Whitesides, Gilman Callsen and Roozbeh Ghaffari in 2008 and is headquartered in Lexington, MA.

Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries.

Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom.

Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT.